ATHIRA PHARMA INC's ticker is ATHA and the CUSIP is 04746L104.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,079,591 | -12.4% | 534,451 | +28.0% | 0.00% | – |
Q2 2023 | $1,232,059 | +41.0% | 417,647 | +19.5% | 0.00% | – |
Q1 2023 | $873,748 | +1027838.8% | 349,499 | +1200.2% | 0.00% | – |
Q4 2022 | $85 | -99.9% | 26,881 | +28.6% | 0.00% | – |
Q3 2022 | $62,000 | -22.5% | 20,895 | -20.8% | 0.00% | – |
Q2 2022 | $80,000 | -87.8% | 26,386 | -45.9% | 0.00% | – |
Q1 2022 | $658,000 | – | 48,761 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
AWH Capital, L.P. | 230,000 | $351,351 | 0.48% |
Perceptive Advisors | 4,797,278 | $14,632,000 | 0.46% |
Ikarian Capital, LLC | 784,200 | $2,393,000 | 0.44% |
Bristlecone Advisors, LLC | 700,926 | $2,138,000 | 0.26% |
Altium Capital Management LP | 200,100 | $610,000 | 0.24% |
RA Capital Management | 1,878,000 | $5,728,000 | 0.15% |
Logos Global Management LP | 220,000 | $671,000 | 0.12% |
PATHSTONE FAMILY OFFICE, LLC | 1,688,840 | $5,150,963 | 0.11% |
Ikarian Capital, LLC | 199,500 | $609,000 | 0.11% |
SG3 Management, LLC | 206,000 | $628,000 | 0.07% |